Related Experiment Videos
Treatment of Grover's disease with calcipotriol (Dovonex)
The British Journal of Dermatology
|May 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial).
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2021
Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate-to-severe atopic dermatitis: an analysis of patient-reported outcomes.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.
Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.
The British journal of dermatology·2026
Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).
The British journal of dermatology·2026
Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study.
The British journal of dermatology·2026
Determinants of real-world sunscreen effectiveness: from ultraviolet radiation photobiology to human behaviour.
The British journal of dermatology·2026
Beyond the Surface of Long-term Survival in Stage IV Melanoma: A Multicenter Cross-sectional Study.
The British journal of dermatology·2026
Efficacy and Safety of Erenumab in Preventive and Therapeutic Treatment of Patients Suffering from Migraine.
Annals of African medicine·2026
Andrographolide as a Promising Diterpenoid Scaffold Against the Neurotropic Nematode Angiostrongylus cantonensis.
Pharmaceuticals (Basel, Switzerland)·2026
Quality by Design-Guided Development of Ketoprofen-Cationic Aspasomes Unlocks the Antifungal Potential of Repurposed Ketoprofen for Topical Therapy.
Pharmaceuticals (Basel, Switzerland)·2026